PBAC Public Summary Documents – July 2019

Page last updated: 15 November 2019

Public Summary Documents relating to the July 2019 PBAC meeting.

• Aflibercept: Solution for intravitreal injection 4 mg in 100 microlitres (40 mg per mL) vial, Solution for intravitreal injection 3.6 mg in 90 microlitres (40 mg per mL) pre-filled syringe; Eylea®
• Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid: Sachets containing oral powder 12.5 g, 30, Sachets containing oral powder 25 g, 30; PKU Explore® 5 and PKU Explore® 10
• Apalutamide: Tablet 60 mg; Erlyand®
• Aprepitant: Capsule 165 mg; Apotex® Aprepitant
• Atezolizumab: Solution concentrate for I.V. infusion 1200 mg in 20 mL; Tecentriq®
• Bezlotoxumab: Solution concentrate for I.V. infusion 1000 mg in 40 mL; Zinplava®
• Blinatumomab: Powder for I.V. infusion 38.5 micrograms; Blincyto®
• Budesonide with Formoterol: Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 120 doses, Pressurised inhalation containing budesonide 100 micrograms with formoterol fumarate dihydrate 3 micrograms per dose, 120 doses; Symbicort® Turbuhaler® 200/6 and Symbicort® Rapihaler® 100/3
• Cabozantinib: Tablet 20 mg, Tablet 40 mg, Tablet 60 mg; Cabometyx®
• Carmellose and Hypromellose: Eye drops containing carmellose sodium 5 mg per mL, 10 mL (Evolve carmellose); Eye drops containing hypromellose 3 mg per mL, 10 mL (Evolve hypromellose); Evolve® carmellose and Evolve®  hypromellose
• Cinacalcet: Tablet 30 mg, 60 mg, 90 mg; Pharmacor Cinacalcet®
• Clostridium Botulinum Type A Toxin-Haemagglutinin Complex: Lyophilised powder for I.M. injection 300 units, Lyophilised powder for I.M. injection 500 units; Dysport®
• Cost-effectiveness review of pneumococcal vaccines for the National Immunisation Program: Pre-filled syringe, 0.5 mL; Prevenar 13® (pneumococcal polysaccharide conjugate 13-valent adsorbed vaccine) and Pneumovax 23® (pneumococcal polysaccharide 23-valent adsorbed vaccine)
• Dabrafenib and Trametinib: dabrafenib: Capsule 50 mg, Capsule 75 mg; trametinib: Tablet 500 microgram, Tablet 2 mg; Tafinlar® and Mekinist®
• Denosumab: Injection 120 mg in 1.7 mL; Xgeva®
• Dolutegravir with Lamivudine: Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg; Dovato®
• Dupilumab: Injection 300 mg in 2 mL single use pre-filled syringe; Dupixent®
• Durvalumab (NSCLC): Solution concentrate for I.V. infusion 120 mg in 2.4 mL, Solution concentrate for I.V. infusion 500 mg in 10 mL; Imfinzi™
• Durvalumab (urothelial cancer): Solution concentrate for I.V. infusion 120 mg in 2.4 mL, Solution concentrate for I.V. infusion 500 mg in 10 mL; Imfinzi™
• Enoxaparin: Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe, Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe; Clexane Forte®, Enoxaparin Winthrop® and Clexane Forte Safety-Lock®
• Evolocumab: Injection 420 mg in 3.5 mL single use pre-filled cartridge, Injection 140 mg in 1 mL single use pre-filled pen; Repatha®
• Ferric derisomaltose: Injection 1000 mg (iron) in 10 mL, Injection 500 mg (iron) in 5 mL; Monofer ®
• Fingolimod: Capsule 250 micrograms (as hydrochloride); Gilenya®
• Fluticasone Furoate: Powder for oral inhalation in breath actuated device containing fluticasone furoate 50 micrograms per dose, 30 doses; Arnuity Ellipta®
• Galcanezumab: Injection 120 mg in 1 mL single use pre-filled pen; Emgality®
• Glycomacropeptide and essential amino acids with vitamins and minerals: Sachets containing oral powder 35 g, 30; TYR Sphere 20®
• Glycomacropeptide formula with docosahexaenoic acid with low phenylalanine: Oral liquid 250 mL, 18; PKU GMPro LQ®
• Influenza Quadrivalent Vaccine: Injection 0.5 mL; Vaxigrip Tetra™
• Influenza Quadrivalent Adjuvanted Vaccine, Influenza Trivalent Adjuvanted Vaccine: Injection 0.5 mL; Fluad® Quad and Fluad®
• Lanadelumab: Solution for injection 300 mg in 2 mL; Takhzyro®
• Lenalidomide: Capsule 5 mg, 10 mg, 15 mg; Revlimid®
• Leuprorelin: Subcutaneous implant 3.6 mg (as acetate) in pre-filled syringe, Subcutaneous implant 5 mg (as acetate) in pre-filled syringe; Lerin®
• Lisdexamfetamine: Capsule containing lisdexamfetamine dimesilate 20 mg, 40 mg and 60 mg; Vyvanse®
• Lumacaftor with Ivacaftor: Sachet containing granules, lumacaftor 100 mg with ivacaftor 125 mg, Sachet containing granules, lumacaftor 150 mg with ivacaftor 188 mg; Orkambi® 100/125 and Orkambi® 150/188
• Mupirocin: Nasal ointment 20 mg (as calcium) per g, 5 g; Medsurge Mupirocin Nasal Ointment®
• Natalizumab: Solution concentrate for I.V. infusion 300 mg in 15 mL; Tysabri®
• Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL; Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
• Nusinersen: Solution for injection 12 mg in 5 mL; Spinraza®
• Obeticholic Acid: Tablet 5 mg, Tablet 10 mg; Ocaliva®
• Octreotide: Injection (modified release) 30 mg (as acetate), vial and diluent syringe; Sandostatin®
• Osimertinib: Tablet 40 mg, Tablet 80 mg; Tagrisso®
• Oxycodone: Capsule containing oxycodone hydrochloride 5 mg; OxyNorm®
• Oxycodone: Tablet containing oxycodone hydrochloride 10 mg (controlled release), Tablet containing oxycodone hydrochloride 15 mg (controlled release), Tablet containing oxycodone hydrochloride 20 mg (controlled release), Tablet containing oxycodone hydrochloride 30 mg (controlled release), Tablet containing oxycodone hydrochloride 40 mg (controlled release), Tablet containing oxycodone hydrochloride 80 mg (controlled release); OxyContin®
• Pembrolizumab (Melanoma): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda®
• Pembrolizumab (NSCLC): Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda®
• Plitidepsin: Powder for I.V. infusion 2 mg with 4 mL solvent; Aplidin®
• Pomalidomide: Capsule 3 mg, Capsule 4 mg; Pomalyst®
• Ramucirumab: 100 mg in 10 mL vial, 500 mg in 50 mL vial; Cyramza®
• Regorafenib: Tablet 40 mg (as monohydrate); Stivarga®
• Rifaximin: Tablet 550 mg; Xifaxan®
• Risankizumab : Injection 75 mg in 0.83 mL pre-filled syringe; Skyrizi®
• Romosozumab: Injection 105 mg in 1.17 mL single use pre-filled pen; Evenity®
• Sapropterin: Powder for oral liquid 100 mg (as dihydrochloride), Powder for oral liquid 500 mg (as dihydrochloride), Tablet (soluble) containing sapropterin dihydrochloride 100 mg; Kuvan®
• Sodium Phenylbutyrate: Granules 483 mg (as sodium) per g, 174 g; Pheburane®
• Terbutaline: Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 100 doses; Bricanyl Turbuhaler®
• Trastuzumab: Powder for I.V. infusion 60 mg, 150 mg and 420 mg; Kanjinti®
• Trastuzumab: Powder for I.V. infusion 150 mg; Herzuma®
• Tyrosine with Carbohydrate: Sachets of oral powder 4 g containing 1 g tyrosine, 30; Tyrosine 1000®